In Vitro Toxicology Testing Market to Grow at 14.1% CAGR to 2021 Led by Systemic Toxicity

Share this news:

In vitro toxicology testing market is to USD 27.36 billion by 2021 from USD 14.15 billion in 2016, at a CAGR of 14.1% between 2016 and 2021 driven by opposition to animal testing, increasing R&D to detect toxicity at early stages

-- The geographic segments included in this report are Europe, North America, Asia, and Rest of the World (RoW). Europe is expected to account for the largest share in the global the in vitro toxicology testing market in 2016. Asia is expected to register the fastest growth in the forecast period. By product, the market includes assays, reagents & lab ware, and services. Based on toxicity endpoints & tests, the market is segmented into systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & irritation, genotoxicity, neurotoxicity, and organ toxicity. The systemic toxicity segment will hold the largest share of the in vitro toxicology testing toxicity endpoints & tests market in 2016.

Complete report on global in-vitro toxicology testing market spread across 255 pages, profiling 10 companies and supported with 107 tables and 135 figures is now available at http://www.rnrmarketresearch.com/in-vitro-toxicology-testing-market-by-product-type-adme-toxicity-endpoints-tests-carcinogenicity-dermal-toxicity-genotoxicity-technology-genomics-transcriptomics-method-cellular-assays-industry-ph-st-to-2021-market-report.html .


The growth of this market is mainly driven by opposition to animal testing, new & promising technologies, increasing R&D to detect toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods. In addition, growing demand for in vitro toxicology in the European market and increasing drug discovery and innovation, & modernization in the in vitro toxicity testing market provides a growing opportunity to this market.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global in vitro toxicology testing market and its sub segments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The report also includes company profiles of market leaders such as Agilent Technologies, Inc. (U.S.), Covance, Inc. (A subsidiary of LabCorp) (U.S.), Bio-Rad Laboratories, Inc. (U.S.), General Electric Company (U.S.), Eurofins Scientific SE (Luxembourg), BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.). Ask for the discount before order a copy of In Vitro Toxicology Testing Market by Product, Type (ADME), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (Genomics, Transcriptomics), Method (Cellular Assays), Industry (Pharmaceutical) - Global Forecast to 2021 research report at http://www.rnrmarketresearch.com/contacts/discount?rname=607628 .

Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub segment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all sub segments. It maps market sizes and growth rates for each sub segment and identifies segments poised for rapid growth in each geographic segment.

On a related note, another research on In Vitro Diagnostics (IVD) Quality Controls Market Forecast to 2020 says, the global IVD quality control products market is expected to reach USD 979.0 million by 2020, growing at a CAGR of 3.6% during the forecast period of 2015 to 2020. The growth in this market is majorly driven by the growing number of accredited clinical laboratories and increasing adoption of third-party quality controls. This research provides comprehensive information on the lucrative emerging markets by product, technology, application, and region. Companies like Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Randox Laboratories, Roche Diagnostics Limited, Abbott Laboratories, Inc., Danaher Corporation, Siemens Healthcare and Sysmex Corporation have been profiled in this 210 pages research report available at http://www.rnrmarketresearch.com/in-vitro-diagnostics-ivd-quality-controls-market-by-application-immunoassay-clinical-chemistry-molecular-diagnostics-microbiology-source-serum-blood-plasma-based-controls-type-instrument-specific-third-st-to-2020-market-report.html .

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: RNR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar
Phone: +1-888-391-5441
Website: http://www.rnrmarketresearch.com

Release ID: 118220

CONTACT ISSUER
Name: Ritesh Tiwari
Email: Send Email
Organization: RNR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar
SUBSCRIBE FOR MORE